Table 1. Clinical syndromes due to mutations in genes encoding fission and fusion machinery components.
Gene | OMIM | Inheritance | Disease | Symptoms | Refs |
---|---|---|---|---|---|
MFN2 | 608507 | AD | Charcot–Marie–Tooth disease type 2A | Distal limb muscle weakness and atrophy, axonal degeneration/regeneration, areflexia, distal sensory loss (pain and temperature more frequent) with or without: (a) CNS involvement (cognitive decline, spasticity, encephalopathy), (b) optic atrophy, (c) hearing loss and (d) vocal cord paresis | [24] |
AR | Charcot–Marie–Tooth disease type 2A | [174] | |||
AD | Hereditary motor and sensory neuropathy VIA | [178] | |||
OPA1 | 605290 | AD | Optic atrophy 1 | Progressive loss of visual acuity, temporal optic nerve pallor, central scotoma with or without: (a) CNS (ataxia, spasticity, hearing loss) and (b) PNS (axonal sensorineural polyneuropathy) symptoms. | [26] |
AD | Optic atrophy plus syndrome | [25] | |||
AR | Behr syndrome | Early-onset optic atrophy accompanied by neurologic features, including ataxia, pyramidal signs, spasticity and mental retardation | [185] | ||
MSTO1 | 617619 | AR/AD | Myopathy and ataxia | Hand and feet muscle weakness, growth impairment, fine tremor, cerebellar hypotrophy with or without: (a) white matter hyperintensities, (b) frontal lobe atrophy and (c) mental retardation | [27] [28] |
DNM1L | 603850 | AR/AD | Encephalopathy | Abnormal brain development, seizures, hepatic dysfunction, encephalopathy, dysmorphism. | [20] [187] |
AD | Optic atrophy 5 | Progressive loss of visual acuity, optic nerve atrophy and central scotoma | [188] | ||
MFF | 614785 | AR | Encephalopathy | Seizures, dysphagia, optic and peripheral neuropathy, developmental delay, microcephaly, cerebellar atrophy and basal ganglia lesions | [22] |
MIEF2 | 615498 | AR | Mitochondrial myopathy | Progressive muscle weakness, intermittent muscle pain and exercise intolerance | [23] |
DNM2 | 602378 | AD | Centronuclear myopathy 1 | Slowly progressive muscle weakness. | [21] |
AD | Charcot–Marie–Tooth disease, axonal type 2M | Distal limb muscle weakness and atrophy and sensory impairment, areflexia +/-neutropenia. | [180] | ||
AD | Charcot–Marie–Tooth disease, dominant intermediate B | ||||
AR | Lethal congenital contracture syndrome 5 | Polyhydramnios, decreased foetal movements, intracranial bleeding, retinal haemorrhage, joint contractures and respiratory insufficiency | |||
SLC25A46 | 610826 | AR | Pontocerebellar hypoplasia type 1 | Early onset of optic atrophy, peripheral axonal sensorimotor neuropathy, ataxia, myoclonus, cerebellar atrophy, hypotonia with variable degree of severity, age at onset and association of symptoms | [189] |
AR | Hereditary sensory motor neuropathy | [31] | |||
AR | Optic atrophy spectrum disorders | [30] | |||
GDAP1 | 606598 | AR | Charcot–Marie–Tooth disease type 4A | Distal limb muscle weakness and atrophy and sensory impairment, areflexia with or without: (a) axonal regeneration and (b) vocal cord paresis | [176] [175] |
AR/AD | Charcot–Marie–Tooth disease type 2K | ||||
AR | Charcot–Marie–Tooth disease type A | ||||
AR | Charcot–Marie–Tooth disease with vocal cord paresis | ||||
INF2 | 610982 | AD | Charcot–Marie–Tooth disease type E | Distal limb muscle weakness and atrophy and sensory impairment, areflexia, sensorineural hearing loss and foot drop | [177] |
AD | Focal segmental glomerulosclerosis | Proteinuria and renal failure | [179] |
A non-exhaustive list of the diseases related to the principal identified mutations in genes encoding the core components of mitochondrial dynamics with associated symptoms. Abbreviations: AD, autosomal dominant; AR, autosomal recessive; CNS, central nervous system; OMIM, Online Mendelian Inheritance in Man®; PNS, peripheral nervous system.